ARKAY Therapeutics
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Lexington Ct, East Windsor, New Jersey...Phone Number
(609) 362-6818Website
www.arkaytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About ARKAY Therapeutics
ARKAY Therapeutics is a biopharmaceutical company focused on developing innovative medicines for Type 2 diabetes and related disorders. Their novel beta-cell-centric product, TriGlytza, aims to address the inadequacies of current therapies by preserving beta cell function and decreasing insulin resistance. The company targets the complex pathophysiology of Type 2 diabetes, particularly in patients with comorbidities such as high blood pressure and arthritis. With a mission to change the treatment trajectory of Type 2 diabetes, ARKAY Therapeutics is dedicated to providing effective solutions for the millions affected by this global epidemic.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ARKAY Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ARKAY Therapeutics is spiking on competitors!
ARKAY Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ARKAY Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ARKAY Therapeutics has new funding data
Check if ARKAY Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if ARKAY Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on ARKAY Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ARKAY Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ARKAY Therapeutics
Compare insights from companies similar to ARKAY Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ARKAY Therapeutics
<$5M
1-10
Private
-
2014
N/A
Company Profile Activity
Activity Insights
ARKAY Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ARKAY Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ARKAY Therapeutics.
ARKAY Therapeutics Tech Stack
A closer look at the technologies used by ARKAY Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARKAY Therapeutics
Sign Up For FreeTo access detailed company insights
ARKAY Therapeutics is a biopharmaceutical company focused on developing innovative medicines for Type 2 diabetes and related disorders. Their novel beta-cell-centric product, TriGlytza, aims to address the inadequacies of current therapies by preserving beta cell function and decreasing insulin resistance. The company targets the complex pathophysi... Read More
